|
NDUFAF4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13430000339798E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.44309999961357E-07 |
| Normal-vs-Stage2 |
1.658310E-03 |
| Normal-vs-Stage3 |
2.618100E-03 |
| Normal-vs-Stage4 |
8.024800E-01 |
| Stage1-vs-Stage2 |
8.681400E-01 |
| Stage1-vs-Stage3 |
4.676600E-01 |
| Stage1-vs-Stage4 |
4.415700E-02 |
| Stage2-vs-Stage3 |
4.315800E-01 |
| Stage2-vs-Stage4 |
3.550000E-02 |
| Stage3-vs-Stage4 |
8.042200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.07800000037628E-08 |
| Normal-vs-AfricanAmerican |
1.099790E-02 |
| Normal-vs-Asian |
4.858100E-03 |
| Caucasian-vs-AfricanAmerican |
6.728100E-02 |
| Caucasian-vs-Asian |
9.255800E-01 |
| AfricanAmerican-vs-Asian |
4.933000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.60819996103601E-09 |
| Normal-vs-Female |
8.604700E-04 |
| Male-vs-Female |
1.142390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.206000E-04 |
| Normal-vs-Extreme_Weight |
1.6798000002094E-07 |
| Normal-vs-Obese |
6.555500E-04 |
| Normal-vs-Extreme_Obese |
9.230200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.919400E-01 |
| Normal_Weight-vs-Obese |
9.146600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.548800E-01 |
| Extreme_Weight-vs-Obese |
3.878000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.478000E-01 |
| Obese-vs-Extreme_Obese |
3.411200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.137700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.59189999959786E-07 |
| Normal-vs-Age(61-80Yrs) |
9.68259999956089E-07 |
| Normal-vs-Age(81-100Yrs) |
3.46230000225489E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.694200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.040600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.317600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.479600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.730290E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.484300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.58760002314062E-09 |
| Normal-VS-Type2 PRCC |
8.432700E-04 |
| Normal-VS-KIRP CIMP |
7.896300E-03 |
| Normal-VS-Unclassified PRCC |
1.01589999745855E-08 |
| Type1 PRCC-VS-Type2 PRCC |
5.103600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.652200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.275160E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.207800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.058140E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.136810E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.65420000106809E-08 |
| Normal-vs-N1 |
1.335560E-02 |
| Normal-vs-N2 |
1.76262999999066E-05 |
| N0-vs-N1 |
3.133900E-02 |
| N0-vs-N2 |
1.086420E-01 |
| N1-vs-N2 |
2.088400E-02 |
|
|
